Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Lipid markers for atherosclerosis.

The American Journal of Cardiology

|February 12, 1986

Summary

This summary is machine-generated.

Atherosclerosis involves platelet interactions and lipid buildup. Impaired cholesterol removal, linked to low apolipoprotein A-I, may drive this cardiovascular disease process.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Problems in the measurement of Lp(a) (millimoles per liter versus milligrams percent).

Journal of the American College of Cardiology·2001

Same author

Very-low-density lipoprotein subfraction composition and metabolism by adipose tissue.

Metabolism: clinical and experimental·1997

Same author

The effect of the treatment of hypothyroidism and hyperthyroidism on plasma lipids and apolipoproteins AI, AII and E.

Clinical endocrinology·1997

Same author

HDL subparticles and coronary artery disease in NIDDM.

Atherosclerosis·1996

Same author

Overview of lipoprotein metabolism: mechanisms involved and conveying this information to patients.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·1995

Same author

The role of lipoprotein A-I and lipoprotein A-I/A-II in predicting coronary artery disease.

Arteriosclerosis, thrombosis, and vascular biology·1995

Same journal

Real-World Effectiveness and Tolerability of Sacubitril/Valsartan in Octogenarian Patients With Heart Failure: Results From the PARACHUTER Study.

The American journal of cardiology·2026

Same journal

ECG-Guided Conduction Pathways as a Lever to Shorten Post-TAVI Hospitalization.

The American journal of cardiology·2026

Same journal

Cystatin-C versus creatinine and kidney function in heart failure with preserved ejection fraction: a SOGALDI-PEF analysis.

The American journal of cardiology·2026

Same journal

Balloon-expandable versus Self-expanding Valves in Patients with Small Aortic Annuli Undergoing Transcatheter Aortic Valve Replacement.

The American journal of cardiology·2026

Same journal

Drug-Coated Balloons versus Drug-Eluting Stents following Coronary Atherectomy in Severely Calcified Lesions: A Systematic Review and Meta-Analysis.

The American journal of cardiology·2026

Same journal

Prehospital Statin Therapy and Outcomes in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

The American journal of cardiology·2026

See all related articles

Area of Science:

Cardiovascular Science
Cell Biology
Metabolic Research

Background:

Atherogenesis is a complex process involving platelet-endothelial interactions and lipid accumulation.
Lipid accumulation depends on the balance between cellular lipoprotein uptake and cholesterol ester removal.
Key cellular mechanisms include low-density lipoprotein (LDL) receptor activity and apolipoprotein A-I regulation.

Purpose of the Study:

To investigate the role of lipid metabolism and apolipoprotein A-I in atherogenesis.
To understand the mechanisms of cellular cholesterol uptake and removal in the context of atherosclerosis.

Main Methods:

Analysis of cellular uptake pathways for lipoproteins.
Evaluation of cholesterol ester removal regulation by apolipoprotein A-I.

Related Experiment Videos

Correlation of apolipoprotein A-I levels with coronary artery disease severity.

Main Results:

Lipid accumulation is determined by the interplay between lipoprotein uptake and cholesterol ester removal.
Apolipoprotein A-I plays a crucial role in regulating cholesterol ester removal.
Low apolipoprotein A-I levels are prevalent in patients with significant coronary artery disease.

Conclusions:

Defects in cellular cholesterol ester removal, potentially due to low apolipoprotein A-I, are implicated in atherogenesis.
Understanding these lipid metabolism pathways is vital for addressing coronary artery disease.
Targeting apolipoprotein A-I or cholesterol removal mechanisms may offer therapeutic strategies.